
The Engine
Description
The Engine, an MIT-founded venture firm based in Cambridge, Massachusetts, is dedicated to supporting "tough tech" startups. Its core mission is to bridge the critical gap between scientific discovery and commercialization, providing essential capital, infrastructure, and expertise to companies tackling some of the world's most significant challenges in areas such as climate change, human health, advanced systems, and industrial technology. The firm's unique approach emphasizes the long-term development of groundbreaking scientific and engineering solutions.
The Engine primarily invests in seed and Series A stage companies, recognizing the substantial capital and time required for deep tech ventures to mature. The firm has demonstrated significant growth in its funding capacity, launching its third fund in 2023 with $390 million, which brought its total assets under management to over $800 million across three funds. This financial backing enables The Engine to provide crucial early-stage support, often acting as the first institutional investor for these capital-intensive startups.
Beyond financial investment, The Engine distinguishes itself by offering extensive operational support, including access to specialized labs, prototyping facilities, and office space within its Cambridge headquarters. This integrated ecosystem is designed to accelerate the development of complex technologies, providing a unique environment for innovation. The firm has built a robust portfolio of over 60 companies, each working on transformative innovations that aim to create new industries and solve pressing societal problems. Their typical initial investment ranges from $1 million to $5 million, reflecting their commitment to foundational support for these ventures.
Investor Profile
The Engine has backed more than 72 startups, with 2 new investments in the last 12 months alone. The firm has led 25 rounds, about 35% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Typical check size: $1M – $5M.
Stage Focus
- Seed (33%)
- Series A (29%)
- Series B (18%)
- Pre Seed (7%)
- Series Unknown (6%)
- Series C (3%)
- Series D (1%)
- Series E (1%)
- Non Equity Assistance (1%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Energy
- Renewable Energy
- Environmental Engineering
- Medical
- Manufacturing
- Energy Storage
- Advanced Materials
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.